# Cybrexa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cybrexa

- Industry: Biotechnology
- Headquarters: New Haven, US
- Website: www.cybrexa.com
- Total disclosed funding: $44M
- Latest round: Series B (Mar 10, 2021)
- Investors on record: 4

## About

Founded in 2017 and based in Connecticut, US, Cybrexa, Inc. operates as a biotechnology company that focuses on developing alphalex™, a health technology platform that aims to target tumor cells. The company was founded by its CEO Per Hellsund. In January 2020, Cybrexa, Inc. raised USD 1.7 million in venture debt financing from unspecified investors, and in March 2021, Cybrexa, Inc. raised USD 25 million in series B funding from new investor Elm Street Ventures. 

Cybrexa’s alphalex™ is a tumor-targeting platform that can be used to improve new applications and combinations of existing cancer therapeutics with its targeted intracellular drug delivery technology. By using alphalex™'s tumor-localizing peptide technology, Cybrexa is developing a new class of small molecule DNA repair inhibitors that could directly target the tumor microenvironment and cure them. The company has a pipeline program called CBX-12 that is a clinical trial for the treatment of solid tumors by using a highly potent topoisomerase I inhibitor exatecan payload. As of March 2021, the CBX-12 is being investigated in collaboration with NCI in pre-clinical safety and efficacy study. 

The company’s future strategy includes supporting the planned advancement of its lead candidate CBX-12 (alphalex™-exatecan) into the clinic.

## Funding rounds

- Series B, Mar 10, 2021, $25M — Elm Street Ventures, HighCape Partners
- Series B, Jun 20, 2019, $13M — Connecticut Innovations, HighCape Partners, Cycle Venture Partners
- Series B, Jun 6, 2017, $6M — Connecticut Innovations, HighCape Partners

## Investors

- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series B
- HighCape Partners (https://capitalatlas.ai/funds/highcape-partners) — Series B
- Cycle Venture Partners (https://capitalatlas.ai/funds/cycle-venture-partners) — Series B
- Elm Street Ventures (https://capitalatlas.ai/funds/elm-street-ventures) — Series B